{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:37:01Z","timestamp":1790627821838,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ophtha.2006.12.029","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T16:07:33Z","timestamp":1177085253000},"page":"1653-1662.e1","source":"Crossref","is-referenced-by-count":72,"title":["Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation"],"prefix":"10.1016","volume":"114","author":[{"given":"Eric D.","family":"Donnenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Grillone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.12.029_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jop.1987.3.43","article-title":"Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing","volume":"3","author":"Waterbury","year":"1987","journal-title":"J Ocul Pharmacol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2006.12.029_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0039-6257(93)90036-7","article-title":"Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy","volume":"38","author":"Abelson","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0891-5520(20)30482-7","article-title":"Infectious conjunctivitis","volume":"6","author":"Syed","year":"1992","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ophtha.2006.12.029_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004397-198302310-00014","article-title":"Corticosteroid therapy of ocular inflammation","volume":"23","author":"Friedlaender","year":"1983","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2006.12.029_bib5","first-page":"831","article-title":"Flurbiprofen and intraocular pressure","volume":"13","author":"Gieser","year":"1981","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archopht.1997.01100160289004","article-title":"Topical 0.5% ketorolac vs. 0.03% flurbiprofen for inhibition of miosis during cataract surgery","volume":"115","author":"Solomon","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2006.12.029_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0886-3350(96)80162-3","article-title":"Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis","volume":"22","author":"Roberts","year":"1996","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2006.12.029_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0886-3350(00)00439-9","article-title":"Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery","volume":"26","author":"Snyder","year":"2000","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2006.12.029_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00055735-199808000-00007","article-title":"Topical nonsteroidal anti-inflammatory agents in ophthalmology","volume":"9","author":"Nichols","year":"1998","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib11","series-title":"Voltaren Ophthalma","year":"2003"},{"key":"10.1016\/j.ophtha.2006.12.029_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0886-3350(13)80153-8","article-title":"Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation","volume":"20","author":"Kraff","year":"1994","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2006.12.029_bib13","series-title":"Acular","year":"2002"},{"key":"10.1016\/j.ophtha.2006.12.029_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0161-6420(88)33034-4","article-title":"The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation","volume":"95","author":"Flach","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.029_bib15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0161-6420(98)99053-4","article-title":"Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery","volume":"105","author":"Flach","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.029_bib16","series-title":"Nevanac","year":"2005"},{"key":"10.1016\/j.ophtha.2006.12.029_bib17","series-title":"Xibrom","year":"2005"},{"key":"10.1016\/j.ophtha.2006.12.029_bib18","series-title":"Xibrom","year":"2006"},{"key":"10.1016\/j.ophtha.2006.12.029_bib19","series-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"141","article-title":"Muscarinic receptor agonists and antagonists","author":"Brown","year":"1996"},{"key":"10.1016\/j.ophtha.2006.12.029_bib20","first-page":"513","article-title":"The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac","volume":"37","author":"Sancilio","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ophtha.2006.12.029_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/jm00377a001","article-title":"Antiinflammatory agents","volume":"27","author":"Walsh","year":"1984","journal-title":"J Med Chem"},{"key":"10.1016\/j.ophtha.2006.12.029_bib22","unstructured":"Hellberg MR, Graff G, Yanni JM, inventors; Alcon Laboratories, Inc., assignee. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders. US Patent 5 475 034. December 12, 1995."},{"key":"10.1016\/j.ophtha.2006.12.029_bib23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1185\/030079906X112471","article-title":"Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium","volume":"22","author":"Waterbury","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2006.12.029_bib24","first-page":"276","article-title":"Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery [in Japanese]","volume":"54","author":"Kawaguchi","year":"2003","journal-title":"Nippon Ganka Kiyo"},{"key":"10.1016\/j.ophtha.2006.12.029_bib25","first-page":"168","article-title":"Effect of bromfenac sodium on postoperative inflammation [in Japanese]","volume":"18","author":"Ohara","year":"2004","journal-title":"Jpn J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2006.12.029_bib26","first-page":"1325","article-title":"Prevention of miosis during cataract surgery by topical bromfenac sodium [in Japanese]","volume":"58","author":"Ohara","year":"2004","journal-title":"Rinsho Ganka"},{"key":"10.1016\/j.ophtha.2006.12.029_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10384-004-0127-2","article-title":"Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis","volume":"48","author":"Miyake-Kashima","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib28","first-page":"1233","article-title":"Efficacy and adverse effects of bromfenac sodium following cataract surgery [in Japanese]","volume":"57","author":"Takamatsu","year":"2003","journal-title":"Rinsho Ganka"},{"key":"10.1016\/j.ophtha.2006.12.029_bib29","first-page":"1299","article-title":"Post-marketing surveillance of bromfenac sodium (Bronuck) ophthalmic solution-use-results surveillance [in Japanese]","volume":"22","author":"Kitao","year":"2005","journal-title":"Atarashii Ganka"},{"key":"10.1016\/j.ophtha.2006.12.029_bib30","first-page":"39","article-title":"Effect of bromfenac sodium (AHR-10282B) eye drops on anterior uveitis [in Japanese]","volume":"91","author":"Usui","year":"1997","journal-title":"Ganka Rinsho Iho"},{"key":"10.1016\/j.ophtha.2006.12.029_bib31","series-title":"Bronuck","year":"2003"},{"key":"10.1016\/j.ophtha.2006.12.029_bib32","series-title":"WHO Handbook for Reporting Results of Cancer Treatment","first-page":"16","year":"1979"},{"key":"10.1016\/j.ophtha.2006.12.029_bib33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ophtha.2006.12.029_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.ophtha.2006.12.029_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.iio.0000212134.83513.11","article-title":"Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug","volume":"46","author":"Donnenfeld","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2006.12.029_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9394(98)00413-9","article-title":"Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial","volume":"127","author":"Heier","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.029_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0161-6420(00)00543-1","article-title":"Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery","volume":"108","author":"Solomon","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.029_bib38","first-page":"717","article-title":"Efficacy of 0.1% bromfenac sodium ophthalmic solution for ocular surface inflammation: a double-masked controlled trial [in Japanese]","volume":"48","author":"Sawa","year":"1997","journal-title":"Nippon Ganka Kiyo"},{"key":"10.1016\/j.ophtha.2006.12.029_bib39","first-page":"309","article-title":"Clinical effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation: optimal frequency of instillation [in Japanese]","volume":"14","author":"Shimizu","year":"1997","journal-title":"Atarashii Ganka"},{"key":"10.1016\/j.ophtha.2006.12.029_bib40","first-page":"45","article-title":"Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation [in Japanese]","volume":"91","author":"Masuda","year":"1997","journal-title":"Ganka Rinsho Iho"},{"key":"10.1016\/j.ophtha.2006.12.029_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/10807680260362687","article-title":"Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study","volume":"18","author":"Taylor","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2006.12.029_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0149-2918(00)88274-0","article-title":"Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma","volume":"21","author":"Schenker","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2006.12.029_bib43","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.150.9.1881","article-title":"The effect of prescribed daily dose frequency on patient medication compliance","volume":"150","author":"Eisen","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ophtha.2006.12.029_bib44","first-page":"233","article-title":"Compliance in subjects prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ophtha.2006.12.029_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1248\/yakushi.121.799","article-title":"Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions [in Japanese]","volume":"121","author":"Ikeda","year":"2001","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ophtha.2006.12.029_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","article-title":"Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro","volume":"32","author":"Cha","year":"2004","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200700019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200700019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:21:05Z","timestamp":1628796065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200700019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S016164200700019X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.12.029","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}